TAG:
laboratory industry
LabCorp Exec Discusses Reasons Behind Its 10-Year Pact with United
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
“This 10-year agreement is unique in the laboratory industry. It speaks to the long-term commitment of both parties.”—Brad Smith, Executive Vice President, Laboratory Corporation of America CEO SUMMARY: It was unprecedented when UnitedHealth …
Like Lab Medicine, THE DARK REPORT is Changing
By R. Lewis Dark | From the Volume XIII No. 13 – September 25, 2006 Issue
ANY PATHOLOGIST OR LABORATORY ADMINISTRATOR who believes there is a status quo in laboratory medicine is ignoring plenty of evidence to the contrary in the healthcare marketplace. Radical evolution is altering the health insurance industry, for the second time in almost 20 years. The Internet and ne…
Buyer of MDS’ Canadian Labs Agrees to Pay C$ 900 Million
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CANADA’S LARGEST CHAIN OF CLINICAL LABORATORIES will change hands in a deal revealed on September 7, 2006 by Toronto’s The Globe and Mail. MDS Inc. will apparently sell its diagnostics division to Borealis Infrastructure Management Inc., a private equit…
Some Random Insights About LabCorp’s Thinking
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CEO SUMMARY: Having scooped up a number of mid-sized laboratory companies in recent years, Laboratory Corporation of America is working to integrate these operations and continue to expand its market share. In a recent conversation with financial analyst Bill Bonnello of Wachovia Securiti…
Walk-In Clinics in Retail Stores Is Hot New Healthcare Trend
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
HERE’S A NEW HEALTHCARE BUSINESS MODEL THAT IS POISED to transform primary care in the United States and is likely to upset any number of traditional clinical relationships in this country. The business model is the walk-in, 15-minute clinic located in a retail store. These types of clinics can al…
Bio-Reference Enters DNA Sequencing Market
By Robert Michel | From the Volume XIII No. 12 – September 5, 2006 Issue
CEOSUMMARY: Bio-Reference Laboratories has just placed an unexpected bet on the wide-open opportunities in genetic testing. The acquisition of GeneDX brings it a respected team of geneticists, capabilities in full DNA sequencing, and a proven track record in testing for rare and complex h…
Medicare’s Lab Competitive Bidding Demonstration
By R. Lewis Dark | From the Volume XIII No. 11 – August 14, 2006 Issue
EVERYONE SHOULD MARK JANUARY 1, 2007 ON THEIR CALENDARS. On that date, just 14 weeks from now, Medicare administrators intend to announce which laboratory bidders will be allowed to provide lab testing services in the laboratory competitive bidding demonstration that was mandated by the 2003 Medicare…
Lab Competitive Bidding Project Slated For Jan. 1
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In a rather quiet fashion, Medicare officials have disclosed timetable dates for implementing the laboratory competitive bidding demonstration mandated by the 2003 Medicare spending bill. Medicare intends to announce the names of participating laboratories by January 1, 2007….
Three Ex-UroCor Execs Acquitted in Jury Trial
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: On June 30, 2006,three former executives of UroCor,Inc.,accused by the U.S. Attorney of anti-kickback and securities violations, stood and heard the jury verdict in their case. “Not guilty on all counts,” stated the jury foreman. Thus ended the effort to convict former ex…
Six Ex-IMPATH Officials Receive Their Sentences
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: Justice has been meted out to six individuals accused of criminal fraud in the Impath,Inc. case. During June, sentences were pronounced for former President and COO Richard P. Adelson and several other defendants. Adelson will serve 42 months in prison, pay a $1.2 million fin…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized